Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight

ClinicalTrials.gov ID: NCT06066515

Public ClinicalTrials.gov record NCT06066515. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 9:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomised, Double-blind, Parallel-group, 76-week, Efficacy and Safety Study of BI 456906 Administered Subcutaneously Compared With Placebo in Participants With Overweight or Obesity Without Type 2 Diabetes

Study identification

NCT ID
NCT06066515
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Boehringer Ingelheim
Industry
Enrollment
726 participants

Conditions and interventions

Conditions

Interventions

  • Placebo Combination Product
  • survodutide Combination Product

Combination Product

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 24, 2023
Primary completion
Dec 1, 2025
Completion
Feb 19, 2026
Last update posted
Mar 11, 2026

2023 – 2026

United States locations

U.S. sites
32
U.S. states
20
U.S. cities
32
Facility City State ZIP Site status
EmVenio Research-Phoenix-69743 Phoenix Arizona 85032
Encompass Clinical Research, Spring Valley Spring Valley California 91978
Diablo Clinical Research Walnut Creek California 94598
Yale University School of Medicine New Haven Connecticut 06519
Alliance for Multispecialty Research, LLC - Doral Doral Florida 33172
University of Florida Gainesville Florida 32610
East Coast Institute for Research, LLC - Jacksonville Jacksonville Florida 32216
New Horizon Research Center-Miami-69732 Miami Florida 33165
West Orange Endocrinology Ocoee Florida 34761
East-West Medical Research Honolulu Hawaii 96814
Solaris Clinical Research Meridian Idaho 83646
Evanston Premier Healthcare Research LLC Skokie Illinois 60077
Velocity Clinical Research-Valparaiso-68883 Valparaiso Indiana 46383
Velocity Clinical Research-Sioux City-69728 Sioux City Iowa 51106
AMR Lexington Lexington Kentucky 40509
L-MARC Research Center Louisville Kentucky 40213
StudyMetrix Research, LLC City of Saint Peters Missouri 63303
Premier Research, Inc. Trenton New Jersey 08611
Velocity Clinical Research - Binghamton Binghamton New York 13905
Southgate Medical Group/ Southgate Medical Park West Seneca New York 14224
Physicians East, PA Greenville North Carolina 27834
Lucas Research, Inc. Morehead City North Carolina 28557
Accellacare-Wilmington-67123 Wilmington North Carolina 28401
Valley Weight Loss Clinic Fargo North Dakota 58104
EmVenio Research-Oklahoma City-70053 Oklahoma City Oklahoma 73139
Trial Management Associates Myrtle Beach South Carolina 29572
Texas Diabetes and Endocrinology Austin Texas 78731
Juno Research, LLC Houston Texas 77040
Diabetes & Glandular Disease Clinic, P.A. San Antonio Texas 78229
Consano Clinical Research Shavano Park Texas 78231
Manassas Clinical Research Center Manassas Virginia 20110
Rainier Clinical Research Center Renton Washington 98057

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 86 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06066515, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 11, 2026 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06066515 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →